Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

Abstract Background Standardized and sensitive assays for Epstein Barr Virus (EBV) are needed to define universal cutoff for treatment initiation in allogeneic hematopoietic stem cells transplant recipients. In a context of accreditation and the availability of EBV international standard, we evaluat...

Full description

Bibliographic Details
Main Authors: Maud Salmona, Karl Stefic, Nadia Mahjoub, Flore Sicre de Fontbrune, Sarah Maylin, François Simon, Catherine Scieux, Gérard Socié, Marie-Christine Mazeron, Jérôme LeGoff
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Virology Journal
Subjects:
EBV
Quantitative PCR
Hematopoietic stem cell transplant
Monitoring
Rituximab
Online Access:https://doi.org/10.1186/s12985-020-1285-7

Internet

https://doi.org/10.1186/s12985-020-1285-7

Similar Items